154 related articles for article (PubMed ID: 21432943)
1. Comparative analysis of germline and somatic microlesion mutational spectra in 17 human tumor suppressor genes.
Ivanov D; Hamby SE; Stenson PD; Phillips AD; Kehrer-Sawatzki H; Cooper DN; Chuzhanova N
Hum Mutat; 2011 Jun; 32(6):620-32. PubMed ID: 21432943
[TBL] [Abstract][Full Text] [Related]
2. Somatic microindels: analysis in mouse soma and comparison with the human germline.
Gonzalez KD; Hill KA; Li K; Li W; Scaringe WA; Wang JC; Gu D; Sommer SS
Hum Mutat; 2007 Jan; 28(1):69-80. PubMed ID: 16977595
[TBL] [Abstract][Full Text] [Related]
3. Brooke-Spiegler syndrome: report of 10 patients from 8 families with novel germline mutations: evidence of diverse somatic mutations in the same patient regardless of tumor type.
Sima R; Vanecek T; Kacerovska D; Trubac P; Cribier B; Rutten A; Vazmitel M; Spagnolo DV; Litvik R; Vantuchova Y; Weyers W; Pearce RL; Pearn J; Michal M; Kazakov DV
Diagn Mol Pathol; 2010 Jun; 19(2):83-91. PubMed ID: 20502185
[TBL] [Abstract][Full Text] [Related]
4. Somatic spectrum of cancer-associated single basepair substitutions in the TP53 gene is determined mainly by endogenous mechanisms of mutation and by selection.
Krawczak M; Smith-Sorensen B; Schmidtke J; Kakkar VV; Cooper DN; Hovig E
Hum Mutat; 1995; 5(1):48-57. PubMed ID: 7728149
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
6. Novel intronic germline FLCN gene mutation in a patient with multiple ipsilateral renal neoplasms.
Gatalica Z; Lilleberg SL; Vranic S; Eyzaguirre E; Orihuela E; Velagaleti G
Hum Pathol; 2009 Dec; 40(12):1813-9. PubMed ID: 19733897
[TBL] [Abstract][Full Text] [Related]
7. Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines.
Zheng L; Wang F; Qian C; Neumann RM; Cheville JC; Tindall DJ; Liu W
Hum Mutat; 2006 Oct; 27(10):1062-3. PubMed ID: 16941491
[TBL] [Abstract][Full Text] [Related]
8. Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.
Cetani F; Pardi E; Ambrogini E; Viacava P; Borsari S; Lemmi M; Cianferotti L; Miccoli P; Pinchera A; Arnold A; Marcocci C
Endocr Relat Cancer; 2007 Jun; 14(2):493-9. PubMed ID: 17639062
[TBL] [Abstract][Full Text] [Related]
9. Mutation rates in the dystrophin gene: a hotspot of mutation at a CpG dinucleotide.
Buzin CH; Feng J; Yan J; Scaringe W; Liu Q; den Dunnen J; Mendell JR; Sommer SS
Hum Mutat; 2005 Feb; 25(2):177-88. PubMed ID: 15643612
[TBL] [Abstract][Full Text] [Related]
10. Somatic versus germline mutation processes at minisatellite CEB1 (D2S90) in humans and transgenic mice.
Buard J; Collick A; Brown J; Jeffreys AJ
Genomics; 2000 Apr; 65(2):95-103. PubMed ID: 10783256
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer.
Nahorski MS; Lim DH; Martin L; Gille JJ; McKay K; Rehal PK; Ploeger HM; van Steensel M; Tomlinson IP; Latif F; Menko FH; Maher ER
J Med Genet; 2010 Jun; 47(6):385-90. PubMed ID: 20522427
[TBL] [Abstract][Full Text] [Related]
12. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
[TBL] [Abstract][Full Text] [Related]
13. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W
Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959
[TBL] [Abstract][Full Text] [Related]
14. Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants.
Greenblatt MS; Beaudet JG; Gump JR; Godin KS; Trombley L; Koh J; Bond JP
Oncogene; 2003 Feb; 22(8):1150-63. PubMed ID: 12606942
[TBL] [Abstract][Full Text] [Related]
15. Microdeletions and microinsertions causing human genetic disease: common mechanisms of mutagenesis and the role of local DNA sequence complexity.
Ball EV; Stenson PD; Abeysinghe SS; Krawczak M; Cooper DN; Chuzhanova NA
Hum Mutat; 2005 Sep; 26(3):205-13. PubMed ID: 16086312
[TBL] [Abstract][Full Text] [Related]
16. Remarkable difference of somatic mutation patterns between oncogenes and tumor suppressor genes.
Liu H; Xing Y; Yang S; Tian D
Oncol Rep; 2011 Dec; 26(6):1539-46. PubMed ID: 21887471
[TBL] [Abstract][Full Text] [Related]
17. Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families.
Agarwal SK; Debelenko LV; Kester MB; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Heppner C; Crabtree JS; Lubensky IA; Zhuang Z; Kim YS; Chandrasekharappa SC; Collins FS; Liotta LA; Spiegel AM; Burns AL; Emmert-Buck MR; Marx SJ
Hum Mutat; 1998; 12(2):75-82. PubMed ID: 9671267
[TBL] [Abstract][Full Text] [Related]
18. Germline and somatic NF1 gene mutations in plexiform neurofibromas.
Upadhyaya M; Spurlock G; Monem B; Thomas N; Friedrich RE; Kluwe L; Mautner V
Hum Mutat; 2008 Aug; 29(8):E103-11. PubMed ID: 18484666
[TBL] [Abstract][Full Text] [Related]
19. Tumors associated with p53 germline mutations: a synopsis of 91 families.
Kleihues P; Schäuble B; zur Hausen A; Estève J; Ohgaki H
Am J Pathol; 1997 Jan; 150(1):1-13. PubMed ID: 9006316
[TBL] [Abstract][Full Text] [Related]
20. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
Crabtree M; Sieber OM; Lipton L; Hodgson SV; Lamlum H; Thomas HJ; Neale K; Phillips RK; Heinimann K; Tomlinson IP
Oncogene; 2003 Jul; 22(27):4257-65. PubMed ID: 12833148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
